Skip to content
OpenCapital
Get started

Crinetics Pharmaceuticals CRNX Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$1.0MBeat by $637.0K
EPS-$1.23Miss by $0.10
Revenue estimate$394.0K
EPS estimate-$1.13

Next report

Aug 4, 2026 (In 6 days)
Revenue estimate$14.8M
EPS estimate-$1.23

Financials

Q2 2025

Income statement

See full
Revenue$1.0M+158%
Operating income-$129.1M-56.0%
Net income-$115.6M-56.2%
EPS (diluted)-$1.23-30.9%

Balance sheet

See full
Cash & equivalents$53.7M-82.2%
Total debt$49.9M-6.3%
Total equity$1.2B+41.0%
Total assets$1.3B+37.8%

Cash flow

See full
Operating cash flow-$85.9M-80.2%
CapEx$3.2M+235%
Free cash flow-$89.1M-83.2%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$2.9B-17.9%
Enterprise value$2.89B-11.8%
P/S2,082.2×-468×

Profitability

See full
Operating margin-30,392.2%+32,199pp
Net margin-26,568.5%+19,500pp
FCF margin-22,269.8%+37,720pp

Returns & leverage

See full
Return on equity-36.9%-6.8pp
Debt / equity0×0.0×
Current ratio17.8×+1.7×

Segments

By segment

See full
Reportable Segment$1.0M—

Versus estimates

Revenue

Q1 2026$10.7MBeat by $2.2MQ4 2025$6.2MBeat by $1.7MQ3 2025$143.0KMiss by $4.2M
Q2 2025$1.0MBeat by $637.0K
Q1 2025$361.0KBeat by $13.1K

Diluted EPS

Q1 2026-$1.23Miss by $0.01Q4 2025-$1.29Beat by $0.08Q3 2025-$1.38Miss by $0.11
Q2 2025-$1.23Miss by $0.10
Q1 2025-$1.04Miss by $0.05Q4 2024-$0.88Beat by $0.04

Ask the moment Crinetics Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Crinetics Pharmaceuticals report Q2 2025 earnings?
Crinetics Pharmaceuticals (CRNX) reported Q2 2025 earnings on August 7, 2025 after market close.
What were Crinetics Pharmaceuticals's Q2 2025 revenue and EPS?
Crinetics Pharmaceuticals reported revenue of $1.0M and eps of $-1.23 for Q2 2025.
Did Crinetics Pharmaceuticals beat estimates in Q2 2025?
Revenue beat the consensus estimate of $394.0K by $637.0K. EPS missed the consensus estimate of $-1.13 by $0.10.
How did Crinetics Pharmaceuticals's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 158.4% from $399.0K a year earlier and eps declined 30.9% from $-0.94.
Where can I find Crinetics Pharmaceuticals's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001193125-25-175498) directly on SEC EDGAR. The filing index links above go to sec.gov.